Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

BACKGROUND: Metformin is widely used to treat gestational diabetes (GDM), but many women remain hyperglycaemic and require additional therapy. We aimed to determine recruitment rate and participant throughput in a randomised trial of glibenclamide compared with standard therapy insulin (added to max...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Rebecca M., Denison, Fiona C., Juszczak, Ed, Bell, Jennifer L., Penneycard, Jessica, Strachan, Mark W. J., Lindsay, Robert S., Alexander, Claire I., Love, Corinne D. B., Whyte, Sonia, Mackenzie, Fiona, Stenson, Ben, Norman, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610470/
https://www.ncbi.nlm.nih.gov/pubmed/28938877
http://dx.doi.org/10.1186/s12884-017-1505-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610470/
https://www.ncbi.nlm.nih.gov/pubmed/28938877
http://dx.doi.org/10.1186/s12884-017-1505-3

Ejemplares similares